Stay updated on Nivolumab Plus Bevacizumab in GBM Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Bevacizumab in GBM Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:48:09.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the temporary government funding notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T05:56:27.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    - A site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and a revision note indicates v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:35:07.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Show glossary feature added to the study page. Metadata wording and revision indicator updated (Last Update Submitted that Met QC Criteria, No FEAR Act data capitalization, and Revision: v3.4.0).
    Difference
    0.2%
    Check dated 2026-01-28T02:21:10.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous revision v3.3.3 was removed; this is a minor version update with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:46:12.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A unified 'Locations' section now lists Massachusetts and Ohio, replacing the prior separate 'Massachusetts Locations' and 'Ohio Locations' entries. The footer link to 'HHS Vulnerability Disclosure' has been removed and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T17:21:17.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Bevacizumab in GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.